Format

Send to

Choose Destination
See comment in PubMed Commons below
J Endocrinol Invest. 2013 Dec;36(11):1105-11.

Industrial endocrine disruptors and polycystic ovary syndrome.

Author information

1
Endocrine Unit, Third Department of Internal Medicine, Medical School University of Athens, Sotiria Hospital, Athens, Greece.

Abstract

Polycystic ovary syndrome (PCOS) is a complex and enigmatic syndrome of unknown origin and etiology enclosing a broad spectrum of phenotypic manifestations. PCOS pathophysiology combines reproductive and metabolic abnormalities into a heterogeneous disorder that has pervasive and devastating health consequences. Inquiring the generative roots of the syndrome, it has become increasingly apparent the role of the environment as a determinant factor. Experimental exposure to industrial endocrine disruptors has been related with the impairment of normal reproductive function and metabolic regulation possibly favoring the development of or aggravating PCOS-resembling clinical disorders. Industrial chemicals may reflect the contributing role of an unfavorable environment to unveil PCOS characteristics in genetically predisposed individuals or further deteriorate the hormonal and fertility imbalances of PCOS-affected females.

PMID:
24445124
DOI:
10.1007/BF03346762
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center